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Purpose/Objective: Currently treatment plan evaluation is 
based on the inspection of the calculated dose distributions 
and dose volume histogram (DVH) parameters. The 
robustness with respect to setup uncertainties of the 
treatment plan is not taken into account in the evaluation 
process. Therefore the risk of missing the target or pushing 
dose to critical organs due to setup uncertainties is 
completely unknown. The purpose of this project is to 
develop a tool to assess the robustness of treatment plans 
taking into account random and systematic setup 
uncertainties. 
Materials and Methods: In order to investigate the effect of 
random and systematic setup errors using Monte Carlo (MC) 
methods, the Swiss Monte Carlo Plan (SMCP) [1] was 
extended accordingly. The impact on the dose distributions is 
evaluated by calculating DVHs and dosimetric parameters as 
a function of the setup error phase-space. The evaluation 
tool allows specifying acceptance criteria by means of dose 
deviations from the original dose distribution. Based on these 
robustness-criteria, a robustness-map is generated dividing 
the setup error phase-space into two regions: one for which 
the robustness-criteria are met (acceptance-space) and 
another treatment-plan where the criteria are not fulfilled. A 
treatment-plan is more robust (in terms of the given 
robustness-criteria), compared to another if the acceptance-
space is larger. In addition, deviations for DVHs or dose 
distributions compared to the original plan can be explored 
across the acceptance-space. 
Results: The robustness evaluation tool is demonstrated on 
various cases and different tumor sites. As an example, 
Figure 1 shows the robustness map comparison of a 2 arcs and 
a 4 arcs plan for a head and neck patient using the VMAT 
delivery technique. In this case, the setup uncertainty phase-
space was defined by translations between [-5mm, 5mm] 
along the x- y- and z-axis. The acceptance-space for the 4 
arcs plan is significantly larger, i.e. more robust with respect 
to setup uncertainties. This is due to the fact that with the 4 
arcs plan, a much better sparing of the spinal cord could be 
achieved. 
Figure1: Robustness-map comparison for a head and neck 
treatment plan applying 2 arcs (left) and 4 arcs (right) using 
the VMAT delivery technique. The acceptance-space 
corresponds to the light grey colored area. The 4 arcs plan is 
superior compared to the 2 arcs plan under the given 
acceptance-criteria. 
 
 
Conclusions: The construction and visualization of 
robustness-maps is useful to assess the robustness of RT 
treatment plans. This work is supported by Varian Medical 
Systems. 
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Purpose/Objective:Cervical cancer patients may benefit 
from intensity-modulated proton therapy (IMPT), preferably 
using a patient-specific beam set-up. However, beam set-up 
optimisation is currently not part of the plan optimisation 
process and the influence of the number of beams on dose 
distributions after robustness evaluation is unknown. The aim 
of this study was to develop a method to determine the 
Pareto front (PF) of robust IMPT plans to enable beam set-up 
selection for robust proton therapy planning in cervical 
cancer. 
Materials and Methods: Planning CTs of 3 cervical cancer 
patients treated in prone position with photons were used. 
Per patient, 3 robustly optimised IMPT base plans using 
different beam set-ups were created with a prescribed dose 
of 46 Gy (23 fractions) to the target (CTV). Beam set-ups, 
planning objectives and minimal requirements for evaluation, 
including the evaluation objectives of interest (CTV D99%, 
rectum V30Gy) which span the objective space, are listed 
(Table). For IMPT plans with a fixed beam set-up, only an 
approximation of the real patient-specific PF can be derived 
and an iterative method to approach this PF was written 
using the scripting facilities in RayStation (RaySearch Labs., 
Sweden). Starting with a base plan, multiple plans with new 
